The case alleges Boston Scientific misled investors about its US EP segment's growth and competitive risks....
SAN DIEGO, March 18, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 20… [+4803 chars]





